Maroon Biotech welcomes contract research and licensing opportunities. Maroon is currently utilizing its expertise in the biophysics of cellular membrane injury to carry out several R&D projects for outside contractors.

Maroon’s intellectual property in the area of cellular membrane repair has numerous compositions that are available for licensing, which include compositions that will enhance gene transfection efficacy and reduce reperfusion injury following myocardial infarction or stroke, and would be particularly valuable opportunities for companies pursuing such technology.

As a privately held biotechnology company, we invite interested partners to evaluate our technology via our Therapeutics & Technology Portfolio or reach out directly to discuss investment, contract, and licensing pathways.